Contribution: Industrial Research Assistance Program – Contributions to Firms
NORTHERN RNA INC.
$498,000.00
UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles
FY 2025-26 · 2025-05-01
Summary
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
717183537
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2027-03-30
Agreement Number
1032265
Agreement Start Date
2025-05-01
Agreement Title
UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles
Agreement Title (French)
UK Biomanufacturing - 10140683 - Vaccin H5Nx - Protection contre le sous-type de grippe Pan-H5Nx : vaccin ARNm utilisant des nanoparticules lipidiques optimisées
Agreement Type
Contribution
Agreement Value
$498,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine.
Description (French)
«Dans le cadre du projet de consortium international» H5Nx Vaccine : Pan-H5Nx subtype Influenza Protection : mRNA Vaccine Using optimized Lipid Nanoparticles”, ce projet propose de développer une plateforme de bioproduction révolutionnaire pour un nouveau vaccin ARNm pan-H5Nx.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Forest Lawn
Federal Riding (French)
Calgary Forest Lawn
Federal Riding Number
48006
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
717183537
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
NORTHERN RNA INC.
Recipient Operating Name
Northern RNA Inc.
Recipient Postal Code
T2A 7H8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1032265
